Cymabay Therapeutics Inc (NASDAQ:CBAY)
| 8.49 BATS BZX Real-Time Price As of 9:42am ET |  +0.15 / +1.80%Today’s Change | 1.67 Today|||52-Week Range 8.75 | +35.41% Year-to-Date |
Latest CBAY News | Press Releases
No recent news for Cymabay Therapeutics Inc.
Today’s Trading
| Previous close | 8.34 |
| Today’s open | 8.31 |
| Day’s range | 8.31 - 8.57 |
| Volume | 3,476 |
| Average volume (3 months) | 812,974 |
| Market cap | $724.9M |
Data as of 9:42am ET, 02/07/2023
Growth & Valuation
| Earnings growth (last year) | -71.14% |
| Earnings growth (this year) | +3.15% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 5.45 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| DITAMCON Distributing C... | -4.00 | -2.34% |
| ---- | ||
| NEUNNeuroGenesis Inc | 0.00 | 0.00% |
| JOEYJoey New York Inc | 0.00 | 0.00% |
Data as of 12:35pm ET, 02/06/2023
Financials
| Next reporting date | March 16, 2023 |
| EPS forecast (this quarter) | -$0.30 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$90.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Newark, California |
Forecasts
